Many studies have shown that clinical survival prognosis was often associated with genetic alterations related to cancer progression.[23,24] While, there is no potential relationship between YKT6 genetic alteration and clinical survival prognosis including OS (P = .495), DFS (P = .304), PFS (P = .125), and DS (P = .268) in UCEC patients. Here, YKT6 is linked to cancer.